Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2005
03/31/2005WO2005028634A2 Improved mva vaccines
03/31/2005WO2005028628A2 Modulation of eif4e expression
03/31/2005WO2005028625A2 Consensus/ancestral immunogens
03/31/2005WO2005028623A2 Broad host range pbbr1-based plasmid mutant derivatives having altered plasmid copy number
03/31/2005WO2005028617A2 Antisense inhibition of laminin-8 expression to inhibit human gliomas
03/31/2005WO2005028615A2 Methods and compositions for detecting promoter activity and expressing fusion proteins
03/31/2005WO2005028515A1 Recombinant antibody against human insulin-like growth factor
03/31/2005WO2005028509A1 Tlr2 antagonistic antibody and use thereof
03/31/2005WO2005028505A2 Multiepitope polypeptides for cancer immunotherapy
03/31/2005WO2005028503A1 Peptide originating in hepatitis c virus
03/31/2005WO2005027980A1 Rna interference for the treatment of gain-of-function disorders
03/31/2005WO2005027979A2 Targeted lipid-drug formulations for delivery of drugs to myeloid and lymphoid immune cells
03/31/2005WO2005027962A1 4’-thionucleosides and oligomeric compounds
03/31/2005WO2005027959A1 Selective inhibition of nf-kappab activation by peptides designed to disrupt nemo oligomerization.
03/31/2005WO2005027844A2 Dna vaccine compositions and methods of use
03/31/2005WO2005027833A2 Compound and method for treating androgen-independent prostate cancer
03/31/2005WO2005027830A2 Chimeric transcription factor decoy oligonucleotides
03/31/2005WO2005027825A2 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
03/31/2005WO2005027711A2 Capsid-modified adenovirus vectors and methods of using the same
03/31/2005WO2005027632A2 Proteins of nutraceutical and biotherapeutic potential
03/31/2005WO2005027631A2 Proteins which confer biotic and abiotic stress resistance in plants
03/31/2005WO2005027629A2 Regulation of cardiac contractility and heart failure propensity
03/31/2005WO2005027628A1 Receptor
03/31/2005WO2005027625A2 Transgenic tieg non-human animals
03/31/2005WO2005014830A3 Utilisation of constructs comprising recombination sequence motifs for enhancing gene expression in moss
03/31/2005WO2005014633A8 Fluorescent protein
03/31/2005WO2005012533A3 Genotoxicity testing
03/31/2005WO2005012495A3 Methods for expression and purification of immunotoxins
03/31/2005WO2005007822A3 Method for assaying protein-protein interaction
03/31/2005WO2005007800A3 Monoclonal antibody against platelet membrane glycoprotein vi
03/31/2005WO2005005632A3 SMALL INTERFERING RNA SPECIFIC TO SUB-UNITS $G(A), $G(A)' AND $G(B) OF THE KINASE PROTEIN CK2, AND THE APPLICATIONS OF THE SAME
03/31/2005WO2005004592A8 Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications
03/31/2005WO2004113573A3 Methods and compositions for analysis of plant gene function
03/31/2005WO2004111189A3 Transgenic animal having an amyloid precursor protein with a modified beta secretase cleavage site
03/31/2005WO2004110964A3 Encoded molecules by translation (emt)
03/31/2005WO2004106532A8 Modified polypeptides for targeting cell-entry of the adenoviruses of subtype b
03/31/2005WO2004104224A3 Markers for lxr activation
03/31/2005WO2004104213A3 Nucleic acids and polypeptides of c1 bacteriophage and uses thereof
03/31/2005WO2004098508A3 Methods for production of non-disease causing hemoglobin by ex vivo oligonucleotide gene editing of human stem/progenitor cells
03/31/2005WO2004096140A3 Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
03/31/2005WO2004094616A9 Silencing transcription by methylation
03/31/2005WO2004094466A3 Recombinant influenza viruses holding a mutation in a transmembrane protein gene
03/31/2005WO2004093645A3 Tn5 transposase mutants and the use thereof
03/31/2005WO2004092351A3 Production of a transgenic avian by cytoplasmic injection
03/31/2005WO2004092326A3 Methods and compositions to increase plant resistance to stress
03/31/2005WO2004089979A3 Adp-ribosylating toxin from listeria monocytogenes
03/31/2005WO2004087744A3 Composition and method for nerve regeneration
03/31/2005WO2004087736A3 Uses of vascular endothelial growth factor and type i collagen inducible protein (vcip)
03/31/2005WO2004087201A3 Mva virus expressing modified hiv envelope, gag, and pol genes
03/31/2005WO2004084939A3 Hiv-peptide-carrier-conjugates
03/31/2005WO2004081189A3 Multimodality imaging of reporter gene expression using a novel fusion vector in living cells and organisms
03/31/2005WO2004080579A3 Liquid tissue preparation from histopatologically processed biological samples, tissues and cells
03/31/2005WO2004080162A3 Integrase mediated avian transgenesis
03/31/2005WO2004080148A3 Novel nucleic acids and polypeptides
03/31/2005WO2004076616A3 Arabidopsis promoters
03/31/2005WO2004074486A3 Fusion proteins of interferon alpha muteins with improved properties
03/31/2005WO2004071272A3 Animal selected for lacking heparan sulfate 3-o-sulfotransferase-1 and uses thereof
03/31/2005WO2004069865A8 Control of plant growth and developmental processes
03/31/2005WO2004064711A3 Modulation of deubiquitinase family members
03/31/2005WO2004056965A3 Nucleic acids encoding antifungal drug targets and methods of use
03/31/2005WO2004048522A3 Modulation of huntingtin interacting protein 2 expression
03/31/2005WO2004048325A3 Modulation of jagged 1 expression
03/31/2005WO2004045547A3 Rnai-based sensors, caged interfering rnas, and methods of use thereof
03/31/2005WO2004044167A3 Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypeptide
03/31/2005WO2004039234A3 Humanized antibodies against the venezuelan equine encephalitis virus
03/31/2005WO2004035759A3 Inhibitory oligonucleotides targeted to matrix metalloproteinase-9
03/31/2005WO2004007705A9 Nucleotide sequences that encode deregulated phosphoglycerate dehydrogenases of coryneform bacteria and method for producing l-serine
03/31/2005WO2003104276A3 Genes and polypeptides relating to hepatocellular or colorectal carcinoma
03/31/2005WO2003103605A3 Flexible vaccine assembly and vaccine delivery platform
03/31/2005WO2003099215A3 Antisense modulation of glucocorticoid receptor expression
03/31/2005WO2003073987A3 Compounds that modulate the activity of ptp-1b and tc-ptp
03/31/2005WO2003062393A3 G protein-coupled receptor variants
03/31/2005WO2003040329A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/31/2005WO2003040323A3 Bacterial ion channel and a method for screening ion channel modulators
03/31/2005WO2003027308A3 56294 and 56629, novel human metalloproteases and uses thereof
03/31/2005WO2003018756A3 Methods for preparing purified prostaglandin e synthase
03/31/2005WO2003012052A3 Specific inhibition of gene expression by small double stranded rnas
03/31/2005WO2002099054A3 Hccss as modifiers of the p53 pathway and methods of use
03/31/2005US20050071901 Soybean plants having superior agronomic performance and methods for their production
03/31/2005US20050071899 Nucleotide sequences comprising stilbene synthase regulatory region for use as tool in enhancing ozone resistance in plants; improving crop yields; delaying senescence
03/31/2005US20050071898 Promotion of somatic embryogenesis in plants by wuschel gene expression
03/31/2005US20050071897 Nucleotide sequences coding gibberellin insensitive (GAI) polypeptides for use in transformation and generation of lodge resistant dwarf plants; enhancing crop yields
03/31/2005US20050071896 Grain kernel comprising starch with high amylose content; improving nutrient quality of crop plants
03/31/2005US20050071895 Transposon expression vector comprising spermatogenesis essential factor (SEF) for use as gene transfer tool in generation of rodent animal models for study of fertility/sterility; heterologous gene expression ; spermatogenesis rescue
03/31/2005US20050071894 Nonhuman model animal lacking the ability to control lymphocyte migration
03/31/2005US20050071893 SiRNA mediated gene silencing in transgenic animals
03/31/2005US20050071891 Repressible sterility of animals
03/31/2005US20050071890 Using vector transformation to generate cell comprising a nd expressing malarial merozoite surface protein (MSP-1) gene sequences; vaccine development and drug screening
03/31/2005US20050070708 May be used for the analysis of nucleic acid sequences by incorporating these derivatives into nucleic acid chains, and also the enzymatic labelling and immobilization or detection of sequences
03/31/2005US20050070700 Equine arteritis virus vaccine
03/31/2005US20050070699 Nucleotide sequences coding low density lipoprotein receptor-related protein 5 for use as tools in diagnosis and treatment of osteoporosis; high bone mass and bone disorders
03/31/2005US20050070697 Pathogen-responsive genes, promoters, regulatory elements, and methods of use for same
03/31/2005US20050070696 Propagating and isolating cell growth factors from prokaryotic systems using ion exchange and reverse phase chromatography; bioreactor and heterologous gene expression
03/31/2005US20050070695 Expression vector comprising nucleotide sequences coding modified cholesterol binding toxin for use as tool in generating vaccine to prevent microorganismal infection; genetic vaccines; bactericides; immunotherapy
03/31/2005US20050070694 Antagonistic anti-htnfsf13b human antibodies
03/31/2005US20050070692 Anti-interleukin-1 beta analogs
03/31/2005US20050070691 Polypeptides of moraxella (branhamella) catarrhalis
03/31/2005US20050070690 Producing tyrosine kinase receptor-related polypeptide for use in tools in identifying modulator for treatment of cell proliferative disorders; biosensors
03/31/2005US20050070689 Nucleotide sequences coding transmembrane activator and CAML interactor (TACI) protein for use in treatment and prevention of autoimmune disorders
03/31/2005US20050070497 Diabetes, insulin resistance and obesity for example
1 ... 2049 2050 2051 2052 2053 2054 2055 2056 2057 2058 2059 2060 2061 2062 2063 2064 2065 2066 2067 2068 2069 ... 4023